Adenovirus infections in heart transplantation

Diana F Florescu, Joong Y. Kwon, Ioana Dumitru

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Adenovirus infections have been associated with significant morbidity and mortality in immunocompromised hosts. The clinical significance of adenovirus disease in heart transplantation is not well-defined; in particular, the significance of adenovirus identification in myocardium remains unclear. Although severe adenovirus disease has been described in heart transplant recipients, adenovirus infections seem to be more frequently associated with increased risk of adverse cardiac events, such as rejection, ventricular dysfunction, coronary vasculopathy, need for retransplantation, and graft loss because of death. Cidofovir is currently considered the standard of treatment for adenovirus disease not responding to reduction of immunosuppression.

Original languageEnglish (US)
Pages (from-to)203-206
Number of pages4
JournalCardiology in review
Volume21
Issue number4
DOIs
StatePublished - Jul 1 2013

Fingerprint

Adenoviridae Infections
Heart Transplantation
Adenoviridae
Ventricular Dysfunction
Immunocompromised Host
Immunosuppression
Myocardium
Morbidity
Transplants
Mortality

Keywords

  • adenovirus disease
  • adenovirus infection
  • heart transplant

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Adenovirus infections in heart transplantation. / Florescu, Diana F; Kwon, Joong Y.; Dumitru, Ioana.

In: Cardiology in review, Vol. 21, No. 4, 01.07.2013, p. 203-206.

Research output: Contribution to journalReview article

Florescu, Diana F ; Kwon, Joong Y. ; Dumitru, Ioana. / Adenovirus infections in heart transplantation. In: Cardiology in review. 2013 ; Vol. 21, No. 4. pp. 203-206.
@article{28f91f37424a4a4788244f5ddf81da63,
title = "Adenovirus infections in heart transplantation",
abstract = "Adenovirus infections have been associated with significant morbidity and mortality in immunocompromised hosts. The clinical significance of adenovirus disease in heart transplantation is not well-defined; in particular, the significance of adenovirus identification in myocardium remains unclear. Although severe adenovirus disease has been described in heart transplant recipients, adenovirus infections seem to be more frequently associated with increased risk of adverse cardiac events, such as rejection, ventricular dysfunction, coronary vasculopathy, need for retransplantation, and graft loss because of death. Cidofovir is currently considered the standard of treatment for adenovirus disease not responding to reduction of immunosuppression.",
keywords = "adenovirus disease, adenovirus infection, heart transplant",
author = "Florescu, {Diana F} and Kwon, {Joong Y.} and Ioana Dumitru",
year = "2013",
month = "7",
day = "1",
doi = "10.1097/CRD.0b013e31828da5b7",
language = "English (US)",
volume = "21",
pages = "203--206",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Adenovirus infections in heart transplantation

AU - Florescu, Diana F

AU - Kwon, Joong Y.

AU - Dumitru, Ioana

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Adenovirus infections have been associated with significant morbidity and mortality in immunocompromised hosts. The clinical significance of adenovirus disease in heart transplantation is not well-defined; in particular, the significance of adenovirus identification in myocardium remains unclear. Although severe adenovirus disease has been described in heart transplant recipients, adenovirus infections seem to be more frequently associated with increased risk of adverse cardiac events, such as rejection, ventricular dysfunction, coronary vasculopathy, need for retransplantation, and graft loss because of death. Cidofovir is currently considered the standard of treatment for adenovirus disease not responding to reduction of immunosuppression.

AB - Adenovirus infections have been associated with significant morbidity and mortality in immunocompromised hosts. The clinical significance of adenovirus disease in heart transplantation is not well-defined; in particular, the significance of adenovirus identification in myocardium remains unclear. Although severe adenovirus disease has been described in heart transplant recipients, adenovirus infections seem to be more frequently associated with increased risk of adverse cardiac events, such as rejection, ventricular dysfunction, coronary vasculopathy, need for retransplantation, and graft loss because of death. Cidofovir is currently considered the standard of treatment for adenovirus disease not responding to reduction of immunosuppression.

KW - adenovirus disease

KW - adenovirus infection

KW - heart transplant

UR - http://www.scopus.com/inward/record.url?scp=84880136747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880136747&partnerID=8YFLogxK

U2 - 10.1097/CRD.0b013e31828da5b7

DO - 10.1097/CRD.0b013e31828da5b7

M3 - Review article

VL - 21

SP - 203

EP - 206

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 4

ER -